Observational studyFuture oncology (London, England)2025

Post-marketing surveillance of tirabrutinib in 189 patients with r/r primary central nervous system lymphoma.

Akira Kawasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.